Progress in Diabetes – 1st Edition

This Book Presents A Comprehensive and Future-Focused Overview Of Progress In Diabetes, Encompassing Global Trends In Disease Burden, Epidemiology, and Risk Factors, Alongside Advances In Genetics, Epigenetics, Type 1 Diabetes Immunotherapy, and Emerging Early-Detection Biomarkers. It Highlights Major Therapeutic Innovations, Including Beta-Cell Regeneration, Novel Drug Classes Such As Sglt2 Inhibitors, Glp-1 Receptor Agonists and Dual Agonists, Precision Medicine Approaches, Tailored Pharmacotherapy and Clinical Trials, As Well As The Role Of Metabolic Surgery and Weight-Loss Interventions In Achieving Remission. The Text Explores Technology-Driven Diabetes Care, With Emphasis On Artificial Intelligence For Prediction and Treatment Planning, Wearable Devices, Continuous Glucose Monitoring, Closed-Loop Insulin Delivery Systems, Telemedicine, and The Use Of Big Data To Advance Research. A Holistic, Complication-Aware Management Approach Is Emphasized, Addressing Mental Health Support, Cardiovascular and Renal Care, Prevention Of Retinopathy and Neuropathy, Lifestyle Modification Through Diet and Exercise, and Diabetes Management In Special Populations. In Addition, The Book Examines Policy, Prevention, and Equity-Driven Strategies, Covering Public Health Initiatives, Global Policies To Improve Access To Care, Reduction Of Disparities In Diabetes Outcomes, Insights From Landmark Randomized Controlled Trials, and Emerging Links Between Diabetes, Cancer, The Microbiome, and Sports Medicine.